Quality is as important as the quantity: role of mucin glycosylation on intestinal barrier function

Comment

Anupama Ravi et al. Gastroenterology. 2007 Dec.

. 2007 Dec;133(6):2065-7.

doi: 10.1053/j.gastro.2007.10.049.

No abstract available

Comment on

Increased susceptibility to colitis and colorectal tumors in mice lacking core 3-derived O-glycans.
An G, Wei B, Xia B, McDaniel JM, Ju T, Cummings RD, Braun J, Xia L. An G, et al. J Exp Med. 2007 Jun 11;204(6):1417-29. doi: 10.1084/jem.20061929. Epub 2007 May 21. J Exp Med. 2007. PMID: 17517967 Free PMC article.

Inhibition of Escherichia coli O157:H7 attachment by interactions between lactic acid bacteria and intestinal epithelial cells.
Kim Y, Kim SH, Whang KY, Kim YJ, Oh S. Kim Y, et al. J Microbiol Biotechnol. 2008 Jul;18(7):1278-85. J Microbiol Biotechnol. 2008. PMID: 18667857
Reduced mucin sulfonation and impaired intestinal barrier function in the hyposulfataemic NaS1 null mouse.
Dawson PA, Huxley S, Gardiner B, Tran T, McAuley JL, Grimmond S, McGuckin MA, Markovich D. Dawson PA, et al. Gut. 2009 Jul;58(7):910-9. doi: 10.1136/gut.2007.147595. Epub 2009 Feb 6. Gut. 2009. PMID: 19201772
Mucin overexpression limits the effectiveness of 5-FU by reducing intracellular drug uptake and antineoplastic drug effects in pancreatic tumours.
Kalra AV, Campbell RB. Kalra AV, et al. Eur J Cancer. 2009 Jan;45(1):164-73. doi: 10.1016/j.ejca.2008.10.008. Epub 2008 Dec 4. Eur J Cancer. 2009. PMID: 19046630
Protein-specific glycosylation: signal patches and cis-controlling peptidic elements.
Hanisch FG, Breloy I. Hanisch FG, et al. Biol Chem. 2009 Jul;390(7):619-26. doi: 10.1515/BC.2009.043. Biol Chem. 2009. PMID: 19284292 Review.
Effect of probiotics on intestinal barrier function.
Mennigen R, Bruewer M. Mennigen R, et al. Ann N Y Acad Sci. 2009 May;1165:183-9. doi: 10.1111/j.1749-6632.2009.04059.x. Ann N Y Acad Sci. 2009. PMID: 19538305 Review.